EA202091878A2 - NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER - Google Patents

NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER

Info

Publication number
EA202091878A2
EA202091878A2 EA202091878A EA202091878A EA202091878A2 EA 202091878 A2 EA202091878 A2 EA 202091878A2 EA 202091878 A EA202091878 A EA 202091878A EA 202091878 A EA202091878 A EA 202091878A EA 202091878 A2 EA202091878 A2 EA 202091878A2
Authority
EA
Eurasian Patent Office
Prior art keywords
peptides
lung cancer
cancer
cells
immunotherapy
Prior art date
Application number
EA202091878A
Other languages
Russian (ru)
Other versions
EA202091878A3 (en
Inventor
Андреа Мар
Тони Вайншенк
Оливер Шор
Дженс Фрицше
Харприт Сингх
Клаудиа Вагнер
Джулия Лейбольд
Колетт Сонг
Original Assignee
Имматикс Байотекнолоджиз Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Имматикс Байотекнолоджиз Гмбх filed Critical Имматикс Байотекнолоджиз Гмбх
Publication of EA202091878A2 publication Critical patent/EA202091878A2/en
Publication of EA202091878A3 publication Critical patent/EA202091878A3/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к пептидам, белкам, нуклеиновым кислотам и клеткам для применения в иммунотерапевтических методах. В частности, настоящее изобретение относится к иммунотерапии рака. Настоящее изобретение относится далее к опухолеассоциированным пептидным эпитопам Т-клеток, в отдельности или в комбинации с другими опухолеассоциированными пептидами, которые могут, например, служить в качестве активных фармацевтических ингредиентов вакцинных композиций, стимулирующих противоопухолевые иммунные ответы, или стимулировать Т-клетки ex vivo с их перенесением в организм пациента. Пептиды, связанные с молекулами главного комплекса гистосовместимости (МНС), или пептиды в отдельности могут быть также мишенями антител, растворимых Т-клеточных рецепторов и других связывающих молекул.The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated peptide epitopes of T cells, alone or in combination with other tumor-associated peptides, which can, for example, serve as active pharmaceutical ingredients in vaccine compositions that stimulate anti-tumor immune responses, or stimulate T cells ex vivo with their transfer to the patient's body. Peptides bound to major histocompatibility complex (MHC) molecules or peptides alone can also be targets for antibodies, soluble T-cell receptors, and other binding molecules.

EA202091878A 2015-04-24 2016-04-22 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER EA202091878A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562152258P 2015-04-24 2015-04-24

Publications (2)

Publication Number Publication Date
EA202091878A2 true EA202091878A2 (en) 2020-11-30
EA202091878A3 EA202091878A3 (en) 2020-12-30

Family

ID=73649872

Family Applications (4)

Application Number Title Priority Date Filing Date
EA202091878A EA202091878A3 (en) 2015-04-24 2016-04-22 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER
EA202091864A EA202091864A3 (en) 2015-04-24 2016-04-22 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER
EA202091879A EA202091879A3 (en) 2015-04-24 2016-04-22 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER
EA202091863A EA202091863A3 (en) 2015-04-24 2016-04-22 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER

Family Applications After (3)

Application Number Title Priority Date Filing Date
EA202091864A EA202091864A3 (en) 2015-04-24 2016-04-22 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER
EA202091879A EA202091879A3 (en) 2015-04-24 2016-04-22 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER
EA202091863A EA202091863A3 (en) 2015-04-24 2016-04-22 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER

Country Status (1)

Country Link
EA (4) EA202091878A3 (en)

Also Published As

Publication number Publication date
EA202091879A2 (en) 2020-11-30
EA202091863A3 (en) 2020-12-30
EA202091863A2 (en) 2020-11-30
EA202091864A3 (en) 2020-12-30
EA202091878A3 (en) 2020-12-30
EA202091879A3 (en) 2020-12-30
EA202091864A2 (en) 2020-11-30

Similar Documents

Publication Publication Date Title
MX2022005060A (en) Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers.
EA202191027A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TUMORS
EA201992664A3 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF OVARIAN CANCER AND OTHER TYPES OF CANCER
PH12018501865A1 (en) Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
EA201890635A1 (en) PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN IMMUNOTHERAPY OF SMALL CELLS OF LUNG AND OTHER CANCER SPECIES
EA202091878A3 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF LUNG CANCER, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER TYPES OF CANCER
EA201992860A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN LUNG CANCER IMMUNOTHERAPY, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC), SMALL-CELL LUNG CANCER (MRL) AND OTHER
EA202092502A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TYPES OF CANCER
EA202191120A2 (en) PEPTIDES AND THEIR COMBINATIONS FOR USE IN IMMUNOTHERAPY OF CANCER
EA202190241A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF CLL AND OTHER TYPES OF CANCER
EA202190465A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY NHL AND OTHER TYPES OF CANCER
EA202191013A3 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR OBTAINING FRAMEWORK FOR USE IN TREATMENT OF PANCREAS CANCER AND OTHER TYPES OF CANCER
EA202190896A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER
EA202190186A1 (en) PEPTIDES, COMBINATIONS OF PEPTIDES AND CELL-BASED MEDICINES FOR USE IN IMMUNOTHERAPY OF BLADDER CANCER AND OTHER TYPES OF CANCER
EA202092543A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND FRAMEWORK FOR USE IN IMMUNOTHERAPY OF RENAL CELL CARCINOMA (RCC) AND OTHER TYPES OF CANCER